IONIS PHARMACEUTICALS INC
zilganersen
Alexander disease
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on zilganersen for Alexander disease is expected Date TBD.
Primary source
· SEC 8-K
verified 12h ago
“Potential approval and launch of zilganersen for Alexander disease (AxD), the first and only investigational medicine to demonstrate clinically meaningful and disease-modifying impact”